Penehyclidine Hydrochloride Pretreatment Ameliorates Rhabdomyolysis-Induced AKI by Activating the Nrf2/HO-1 Pathway and Alleviating [corrected] Endoplasmic Reticulum Stress in Rats. The

PLoS One. 2016 Mar 17;11(3):e0151158. doi: 10.1371/journal.pone.0151158. eCollection 2016.

Abstract

Acute kidney injury (AKI) is one of the most severe complications of rhabdomyolysis (RM). The underlying mechanisms and potential preventions need to be investigated. Penehyclidine hydrochloride (PHC) was reported to ameliorate renal ischemia-reperfusion injury, but the effect of PHC on RM-reduced AKI is unknown. In this study, we established a rat model of RM-induced AKI using an intramuscular glycerol injection in the hind limbs. Rats were pretreated with PHC before the glycerol injection, and the heme oxygenase-1 (HO-1) inhibitor ZnPP was introduced to evaluate the effect of HO-1 on RM-induced AKI. PHC pretreatment ameliorated the pathological renal injury and renal dysfunction, and decreased the renal apoptosis rate in RM-induced AKI. PHC significantly up-regulated HO-1 expression, increased HO-1 enzymatic activity and decreased the accumulation of myoglobin in renal tissues. This effect was partly inhibited by ZnPP. PHC pretreatment also effectively up-regulated nuclear factor erythroid 2-related factor 2 (Nrf2) and down-regulated glucose regulated protein 78 (GRP78) and caspase-12 at both the gene and protein levels. These results suggest that the protective effects of PHC pretreatment on RM-induced AKI occur at least in part through activating the Nrf2/HO-1 pathway and alleviating endoplasmic reticulum stress (ERS) in rat renal tissues.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / drug therapy*
  • Acute Kidney Injury / etiology*
  • Acute Kidney Injury / metabolism
  • Acute Kidney Injury / pathology
  • Animals
  • Cholinergic Antagonists / therapeutic use*
  • Endoplasmic Reticulum Stress / drug effects*
  • Heme Oxygenase-1 / metabolism
  • Kidney / drug effects*
  • Kidney / metabolism
  • Kidney / pathology
  • Male
  • NF-E2-Related Factor 2 / metabolism
  • Quinuclidines / therapeutic use*
  • Rats
  • Rats, Sprague-Dawley
  • Rhabdomyolysis / complications*
  • Signal Transduction / drug effects

Substances

  • Cholinergic Antagonists
  • NF-E2-Related Factor 2
  • Nfe2l2 protein, rat
  • Quinuclidines
  • penehyclidine
  • Heme Oxygenase-1

Grants and funding

This study was supported by the grants from the Application Basic Research Project of Hebei Province (13967702D), the Fund of Chinese PLA 12th Five-Year Plan for Medical Sciences (BWS11J058, CWS12J061) and the Youth Cultivation Project of Chinese PLA for Medical Sciences (13QNP013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.